K Denicoff
Overview
Explore the profile of K Denicoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Altshuler L, Keck Jr P, McElroy S, Suppes T, Brown E, Denicoff K, et al.
Bipolar Disord
. 2001 Mar;
1(1):61-5.
PMID: 11256659
Background: Gabapentin, a new anti-epileptic agent, has been anecdotally reported to be effective in the treatment of mania. We systematically assessed the response rate in bipolar patients being treated adjunctively...
2.
Frye M, Ketter T, Altshuler L, Denicoff K, Dunn R, Kimbrell T, et al.
J Affect Disord
. 1998 Jul;
48(2-3):91-104.
PMID: 9543198
Traditional neuroleptics are often utilized clinically for the management of bipolar disorder. Although effective as antimanic agents, their mood stabilizing properties are less clear. Additionally, their acute clinical side effect...
3.
McElroy S, Frye M, Denicoff K, Altshuler L, Nolen W, Kupka R, et al.
J Affect Disord
. 1998 Jun;
49(2):119-22.
PMID: 9609675
Background: We evaluated the response to olanzapine in 14 consecutive patients with bipolar I disorder who were inadequately responsive to standard psychotropic agents. Methods: Fourteen patients with bipolar I disorder...
4.
Mitchell P, Manji H, Chen G, Jolkovsky L, Denicoff K, Schmidt M, et al.
Am J Psychiatry
. 1997 Feb;
154(2):218-23.
PMID: 9016271
Objective: Previous investigations have suggested the involvement of signal-transducing guanine-nucleotide-binding proteins (G proteins) both in the mechanism of action of lithium and in the pathophysiology of bipolar affective disorder. To...
5.
Post R, Ketter T, Denicoff K, Pazzaglia P, Leverich G, Marangell L, et al.
Psychopharmacology (Berl)
. 1996 Nov;
128(2):115-29.
PMID: 8956373
With the increasing recognition of lithium's inadequacy as an acute and prophylactic treatment for many patients and subtypes of bipolar illness, the search for alternative agents has centered around the...
6.
Post R, Ketter T, Pazzaglia P, Denicoff K, George M, Callahan A, et al.
Epilepsy Res Suppl
. 1996 Jan;
11:153-80.
PMID: 9294735
Bipolar affective illness represents a syndrome not readily treated by single agents. Approximately 50% of patients are inadequately responsive to lithium and the majority of patients require supplemental antidepressants, antimanic,...
7.
Ketter T, Flockhart D, Post R, Denicoff K, Pazzaglia P, Marangell L, et al.
J Clin Psychopharmacol
. 1995 Dec;
15(6):387-98.
PMID: 8748427
Recent advances in molecular pharmacology have allowed the characterization of the specific isoforms that mediate the metabolism of various medications. This information can be integrated with older clinical observations to...
8.
Altshuler L, Curran J, Hauser P, Mintz J, Denicoff K, Post R
Am J Psychiatry
. 1995 Aug;
152(8):1139-44.
PMID: 7625460
Objective: Accumulating evidence suggests a greater number of T2 abnormalities in the brains of patients with bipolar I disorder. The authors sought to evaluate the presence of signal "hyperintensities" in...
9.
Post R, Ketter T, Pazzaglia P, George M, Marangell L, Denicoff K
Neuropsychobiology
. 1993 Jan;
27(3):132-7.
PMID: 8232827
There is increasing recognition that lithium is inadequate in the treatment of up to 50% of bipolar patients. In addition to subgroups that are nonresponsive from the outset, loss of...
10.
Post R, Altshuler L, Ketter T, Denicoff K, Weiss S
Adv Neurol
. 1991 Jan;
55:239-77.
PMID: 2003410
No abstract available.